ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
A group of Dutch companies, academic institutes, and public organizations has established the BioMedical Materials (BMM) Program. Using a budget of about $150 million over five years, the public-private partnership intends to develop medical applications, establish intellectual property, and publish scientific papers that bolster the Netherlands' position in the biomedical materials arena. Companies in the consortium include DSM, Organon, Fuji Photo Film's life sciences division, Pharming, and Medtronic. BMM will begin operations in the third quarter, and the first research project will start in 2007.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X